講演情報
[ES1-2]Advancing Management of Perianal
Fistulizing Crohn’s Disease: Latest
Evidence with Guselkumab
*Stefan Schreiber1 (1. Department Medicine I, University Hospital Schleswig-Holstein, Kiel University, Germany)